Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Tramadol for Post-Spinal Shivering in C-Section
NCT05616364Phase 2Unknown
- Start
- Mar 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial of dexmedetomidine in postanesthetic shivering (PAS) (2 arms). Primary endpoint: Assessment of post spinal shivering by observing grades of shivering at 10 minutes. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on NCT05616364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05616364.